{
    "clinical_study": {
        "@rank": "159617", 
        "arm_group": [
            {
                "arm_group_label": "19 G Flex Needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Device: Expect\u2122 Endoscopic Ultrasound Aspiration Needle (19 G Flex)"
            }, 
            {
                "arm_group_label": "22 G Needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Device: Expect\u2122 Endoscopic Ultrasound Aspiration Needle (22 G)"
            }, 
            {
                "arm_group_label": "19 G Needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Device: Expect\u2122 Endoscopic Ultrasound Aspiration Needle (19 G)"
            }
        ], 
        "brief_summary": {
            "textblock": "To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic\n      cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard\n      diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of\n      mucinous (pre-malignant) and non-mucinous cysts."
        }, 
        "brief_title": "Evaluation of PCLs Using Three EUS-FNA Needles", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pancreatic Cystic Lesions", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pancreatic cystic lesion measuring 13mm or greater in largest diameter.\n\n          -  Indicated for EUS evaluation of the PCL including EUS-FNA.\n\n          -  Age 18 years of age or older.\n\n          -  Willing and able to comply with the study procedures and provide written informed\n             consent form to participate in the study.\n\n        Exclusion Criteria:\n\n          -  Cysts in which FNA is not indicated based on review by the clinician,  including\n             potential concern of blood vessel location relative to the cyst.\n\n          -  Requirement for anticoagulation using clopidogril, warfarin, or other long  acting\n             antiplatelet agents (with the exception of aspirin) that cannot be safely stopped\n             according to institutional guidelines.\n\n          -  Standard contraindications for EUS.\n\n          -  Known pancreatic pseudocyst.\n\n          -  Pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711294", 
            "org_study_id": "CDM00049998", 
            "secondary_id": "E7084"
        }, 
        "intervention": [
            {
                "arm_group_label": "19 G Flex Needle", 
                "description": "Fine Needle Aspiration of PCL with a 19 G Flex needle. If unsuccessful, a salvage procedure will be done with 19 G or 22 G needle.", 
                "intervention_name": "19 G Flex Needle", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "22 G Needle", 
                "description": "Fine Needle Aspiration of PCL with a 22 G needle. If unsuccessful, a salvage procedure will be done with 19 G Flex needle.", 
                "intervention_name": "22 G Needle", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "19 G Needle", 
                "description": "Fine Needle Aspiration of PCL with a 19 G needle. If unsuccessful, a salvage procedure will be done with 19 G Flex needle.", 
                "intervention_name": "19 G Needle", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Pancreatic Cystic Lesions", 
            "PCL", 
            "EUS-FNA"
        ], 
        "lastchanged_date": "November 27, 2013", 
        "location": [
            {
                "contact": {
                    "email": "faigel.douglas@mayo.edu", 
                    "last_name": "Douglas Faigel, MD", 
                    "phone": "480-301-8000"
                }, 
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85259"
                    }, 
                    "name": "Mayo Clinic"
                }, 
                "investigator": {
                    "last_name": "Douglas Faigel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wallace.michael@mayo.edu", 
                    "last_name": "Michael B Wallace, MD", 
                    "phone": "904-953-7382"
                }, 
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32224"
                    }, 
                    "name": "Mayo Clinic"
                }, 
                "investigator": {
                    "last_name": "Michael B Wallace, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "moalhadd@iupui.edu", 
                    "last_name": "Mohammad Al-Haddad, MD", 
                    "phone": "317-948-8125"
                }, 
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Mohammad Al-Haddad, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "as3614@mail.cumc.columbia.edu", 
                    "last_name": "Amrita Sethi, MD", 
                    "phone": "212-305-1909"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "New York Presbyterian Hospital/Columbia University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Amrita Sethi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sandeep@lakhtakia.com", 
                    "last_name": "Sandeep Lakhtakia, MD", 
                    "phone": "91-40-2337-8888"
                }, 
                "facility": {
                    "address": {
                        "city": "Hyderabad", 
                        "country": "India", 
                        "zip": "500 082"
                    }, 
                    "name": "Asian Institute of Gastroenterology"
                }, 
                "investigator": {
                    "last_name": "Sandeep Lakhtakia, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "India"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multicenter, Prospective, Randomized Study on Endosonographic Evaluation of Pancreatic Cystic Lesions Using 22 G, 19 G, and Flexible 19 G Fine Needle Aspiration", 
        "overall_contact": {
            "email": "lina.ginnetti@bsci.com", 
            "last_name": "Lina Ginnetti", 
            "phone": "508-683-4512"
        }, 
        "overall_contact_backup": {
            "email": "nguyet.nguyen2@bsci.com", 
            "last_name": "Nguyet T Nguyen", 
            "phone": "508-683-4065"
        }, 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Michael B Wallace, MD,MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Volume of aspirated cyst fluid as a function of estimated maximal volume, based on pre-aspiration EUS measure of cyst diameter (s) (% aspiration of total estimated volume)", 
            "measure": "Volume of aspirated cyst fluid as a function of estimated maximal volume", 
            "safety_issue": "No", 
            "time_frame": "At procedure (Up to 1 hour)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711294"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Occurrence, severity and relatedness of adverse events to the needle and procedure.", 
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Extent of cyst aspiration as measured by reduction of maximal cyst diameter before and after FNA (converted to volume by standard geometric formulation).", 
                "measure": "Extent of cyst aspiration", 
                "safety_issue": "No", 
                "time_frame": "Procedure (Up to 1 hour)"
            }, 
            {
                "description": "Successful echoendoscopic fine needle aspiration of PCL, defined as complete cyst aspiration (final cyst maximal diameter of less than 5mm) or collection of aspirate adequate to perform two standard assays: cytology and carcinoembryonic antigen (CEA) (sample volume of 3 cc or more)", 
                "measure": "Successful echoendoscopic fine needle aspiration of PCL", 
                "safety_issue": "No", 
                "time_frame": "At procedure"
            }, 
            {
                "description": "Ability to reach and penetrate the PCL, stratified by route of access and PCL location.", 
                "measure": "Ability to reach and penetrate the PCL", 
                "safety_issue": "No", 
                "time_frame": "Procedure (Up to 1 hour)"
            }, 
            {
                "measure": "Number of EUS-FNA needles and EUS-FNA needle passes used.", 
                "safety_issue": "No", 
                "time_frame": "Procedure (Up to 1 hour)"
            }, 
            {
                "measure": "Time needed for aspiration for each pass and time from first needle pass in to last needle pass out.", 
                "safety_issue": "No", 
                "time_frame": "Procedure (Up to 1 hour)"
            }, 
            {
                "description": "Ease of needle passage in and out of echoendoscope and quality of needle visualization inside the cyst, categorized as Excellent, Very Good, Good, Fair, and Poor", 
                "measure": "Ease of needle passage and quality of needle visualization inside the cyst", 
                "safety_issue": "No", 
                "time_frame": "Procedure (Up to 1 hour)"
            }, 
            {
                "description": "Accuracy of two EUS-FNA-based standard assays (cytology and CEA) as a diagnostic measure of disease state categorized as one of the following: serous cyst, mucinous cyst, intra papillary mucinous neoplasm (IPMN), or pseudocyst.", 
                "measure": "Accuracy of two EUS-FNA-based standard assays (cytology and CEA) as a diagnostic measure of disease state", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Post EUS-FNA patient management plan (clinical and/or imaging surveillance, percutaneous drainage, surgical removal).", 
                "measure": "Post EUS-FNA patient management plan", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Diagnosis will determine type of cyst: serous, mucinous, intra papillary mucinous neoplasm (IPMN) or pseudocyst", 
                "measure": "Impact of EUS-FNA based assays on diagnosis to determine type of cyst", 
                "safety_issue": "No", 
                "time_frame": "Procedure - 30 days after procedure"
            }, 
            {
                "measure": "Rate of cross-over to salvage arm", 
                "safety_issue": "No", 
                "time_frame": "Procedure (Immediate)"
            }
        ], 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}